Adjuvant capecitabine in biliary tract cancer: a standard option?

被引：27
|
作者：
Malka, David [1 ]
Edeline, Julien [2 ]
机构：
[1] Univ Paris Saclay, Gustave Roussy, Dept Canc Med, Villejuif, France
[2] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France
来源：
LANCET ONCOLOGY | 2019年 / 20卷 / 05期
关键词：
GEMCITABINE; CHEMOTHERAPY; TRIAL;
D O I：
10.1016/S1470-2045(19)30022-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：606 / 608
页数：4
相关论文
共 50 条
  • [41] Postoperative adjuvant tislelizumab plus lenvatinib and capecitabine for biliary tract cancer: Interim results of a prospective, single-arm, phase II study
    Feng, Y.
    Zhang, N.
    Zhao, Y.
    Pan, Q.
    Mao, A.
    Zhu, W.
    Lin, Z.
    Wang, L.
    Wang, Y. L.
    Zhou, J.
    Zhang, T.
    Wang, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S119 - S119
  • [42] Capecitabine and cisplatin as a second-line chemotherapy for patients with advanced biliary tract cancer
    Shin, Kabsoo
    Lee, In Seok
    Hong, Tae Ho
    Kim, Joori
    Lee, Myung Ah
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [43] Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer
    Hong, Yong Sang
    Lee, Jeeyun
    Lee, Sang Cheol
    Hwang, In Gyu
    Choi, Seong-Ho
    Heo, Jin-Seok
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 321 - 328
  • [44] Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer
    Skipworth, J. R. A.
    Damink, S. W. M. Olde
    Imber, C.
    Bridgewater, J.
    Pereira, S. P.
    Malago, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (09) : 1063 - 1078
  • [45] Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer
    Yong Sang Hong
    Jeeyun Lee
    Sang Cheol Lee
    In Gyu Hwang
    Seong-Ho Choi
    Jin-Seok Heo
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 321 - 328
  • [46] Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: A phase 2 study
    Rubovszky, G.
    Lang, I.
    Ganofszky, E.
    Horvath, Z.
    Juhos, E.
    Nagy, T.
    Szabo, E.
    Szentirmay, Z.
    Budai, B.
    Hitre, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (18) : 3806 - 3812
  • [47] A retrospective study of the efficacy of gemcitabine combined with capecitabine versus capecitabine alone for biliary tract cancer after curative resection
    Ma, J.
    Yang, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S1462 - S1463
  • [48] Gemcitabine, capecitabine and oxaliplatin in advanced biliary tract carcinoma
    Larsen, Finn Ole
    Mellergaard, Anne Haahr
    Hoegdall, Dan Taksony Solyom
    Jensen, Lars Henrik
    ACTA ONCOLOGICA, 2014, 53 (10) : 1448 - 1450
  • [49] Chemotherapy combined with targeted therapy and immunotherapy is an option in advanced biliary tract cancer
    Ge, Penglei
    Wu, Yang
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [50] Gemcitabine plus capecitabine in biliary cancer
    Nature Clinical Practice Oncology, 2005, 2 (6): : 279 - 280
12345